SEC Company Response from PALISADE BIO, INC. (PALI) (CIK 0001357459) (PALI) — Jul 25, 2019
PALISADE BIO, INC. (PALI) (CIK 0001357459)
Date: July 25, 2019 · CIK: 0001357459 · Accession: 0001171843-19-004824
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-232273
Referenced dates: June 27, 2019
Letter
RE: Neuralstem, Inc.
July 25, 2019
Office of Healthcare and Insurance
Division of Corporation Finance
United States Securities and Exchange Commission
Washington, DC 20549
Registration Statement on Form S-1
Originally Filed June 21, 2019
Amended on July 25, 2019
File No. 333-232273
To Whom it May Concern:
We are in receipt of your letter dated June 27, 2019 advising us that the above referenced registration statement will not be reviewed. Pursuant to a telephonic conversation between our legal counsel and the staff, we have been informed that we can request acceleration to become effective at 5:15 p.m. EST, on Thursday July 25, 2019. Accordingly, please be advised that Neuralstem, Inc. hereby requests that the above referenced registration statement be declared effective at 5:15 p.m. EST, on Thursday, July 25, 2019 or as soon as practicable thereafter.
We hereby acknowledge that:
1. should the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, such action will not foreclose the Commission from taking any action with respect to the filing;
2. the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, will not relieve the Issuer from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
3. The Issuer may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
/s/ Kenneth Carter
Show Raw Text
CORRESP
1
filename1.htm
July 25, 2019
Office of Healthcare and Insurance
Division of Corporation Finance
United States Securities and Exchange Commission
Washington, DC 20549
RE: Neuralstem,
Inc.
Registration Statement on Form S-1
Originally Filed June 21, 2019
Amended on July 25, 2019
File No. 333-232273
To Whom it May Concern:
We are in receipt of your letter dated June 27, 2019 advising us
that the above referenced registration statement will not be reviewed. Pursuant to a telephonic conversation between our legal
counsel and the staff, we have been informed that we can request acceleration to become effective at 5:15 p.m. EST, on Thursday
July 25, 2019. Accordingly, please be advised that Neuralstem, Inc. hereby requests that the above referenced registration statement
be declared effective at 5:15 p.m. EST, on Thursday, July 25, 2019 or as soon as practicable thereafter.
We hereby acknowledge that:
1. should the Commission or the staff, acting pursuant to delegated authority, in declaring the filing
effective, such action will not foreclose the Commission from taking any action with respect to the filing;
2. the action of the Commission or the staff, acting pursuant to delegated authority, in declaring
the filing effective, will not relieve the Issuer from its full responsibility for the adequacy and accuracy of the disclosure
in the filing; and
3. The Issuer may not assert staff comments and the declaration of effectiveness as a defense in any
proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
/s/ Kenneth Carter
Kenneth Carter, PhD
Executive Chairman